Diabetic retinopathy and dysregulated innate immunity

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)


Diabetic retinopathy (DR) is the progressive degeneration of retinal blood vessels and neurons. Inflammation is known to play an important role in the pathogenesis of DR. During diabetes, metabolic disorder leads to the release of damage-associated molecular patterns (DAMPs) both in the retina and elsewhere in the body. The innate immune system provides the first line of defense against the DAMPs. In the early stages of DR when the blood retinal barrier (BRB) is intact, retinal microglia and the complement system are activated at low levels. This low-level of inflammation (para-inflammation) is believed to be essential to maintain homeostasis and restore functionality. However, prolonged stimulation by DAMPs in the diabetic eye leads to maladaptation of the innate immune system and dysregulated para-inflammation may contribute to DR development. In the advanced stages of DR where immune privilege is comprised, circulating immune cells and serum proteins may infiltrate the retina and participate in retinal chronic inflammation and retinal vascular and neuronal damage. This review discusses how the innate immune system is activated in diabetes and DR. The view also discusses why the protective immune response becomes detrimental in DR.

Original languageEnglish
Pages (from-to)39-46
Number of pages8
JournalVision Research
Early online date02 Jun 2017
Publication statusPublished - Oct 2017


  • Journal Article

Fingerprint Dive into the research topics of 'Diabetic retinopathy and dysregulated innate immunity'. Together they form a unique fingerprint.

Cite this